Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts - Cellular and Molecular Aspects

By Fu F.   Li W.   Lu L.   Thomson A.W.   Fung J.J.   Qian S.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1244-1244

Elsevier

Access to resources Recommend Favorite

Trafficking of APC from liver allografts of Flt3L-treated donors: augmentation of potent allostimulatory cells in recipient lymphoid tissue is associated with a switch from tolerance to rejection

By Steptoe R.J.   Li W.   Fu F.   O'Connell P.J.   Thomson A.W.  

Transplant Immunology, Vol. 7, Iss. 1, 1999-03 ,pp. : 51-57

Elsevier

Access to resources Recommend Favorite

CTLA4-Ig Treatment Prolongs Rat Orthotopic Liver Graft Survival

By Tu Y.   Rehman A.   Flye M.W.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1036-1037

Elsevier

Access to resources Recommend Favorite

Adenovirus-Mediated Gene Transfer of CTLA4Ig to Liver Allografts Results in Prolonged Survival and Local T-Cell Anergy

By Olthoff K.M.   Da Chen X.   Gelman A.   Turka L.   Shaked A.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1030-1031

Elsevier

Access to resources Recommend Favorite

Effect of Gene Gun-Mediated CTLA4IG and Fas Ligand Gene Transfection on Concordant Xenogeneic Islet Graft Rejection

By Guo Z.   Mital D.   Mo Y.-Y.   Tian Y.   Shen J.   Chong A.S.F.   Foster P.   Sankary H.   McChesney L.   Jensik S.C.   Williams J.W.  

Transplantation Proceedings, Vol. 30, Iss. 2, 1998-03 ,pp. : 589-589

Elsevier

Access to resources Recommend Favorite